Immune Checkpoint Inhibitor-Associated Myocarditis: A Run of Bad Luck or Rather Deficient-Monitoring Protocol?

Immune checkpoint inhibitors (ICIs) can induce immunity-related adverse events. We demonstrate the clinical use of cardiac magnetic resonance and endomyocardial biopsy in the diagnosis and subsequent monitoring of ICI-associated myocarditis, suggesting the need to establish and evaluate a cardiac mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Chatzantonis, Grigorios, Evers, Georg, Meier, Claudia, Bietenbeck, Michael, Florian, Anca, Klingel, Karin, Bleckmann, Annalen, Yilmaz, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298681/
https://www.ncbi.nlm.nih.gov/pubmed/34317309
http://dx.doi.org/10.1016/j.jaccas.2019.12.047
Descripción
Sumario:Immune checkpoint inhibitors (ICIs) can induce immunity-related adverse events. We demonstrate the clinical use of cardiac magnetic resonance and endomyocardial biopsy in the diagnosis and subsequent monitoring of ICI-associated myocarditis, suggesting the need to establish and evaluate a cardiac monitoring protocol for patients under ICI therapy. (Level of Difficulty: Intermediate.)

Ejemplares similares